Our Ideas - Genetics

These are the posts from the Our Ideas section that have been tagged with Genetics.

To see all tags used in our posts, click here.

runway-sea-sky_Blue-Latitude-Health

The 2017 trends issue of Perspective magazine is live

Blue Latitude Health | 9th January 2017

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in supporting and enhancing these interactions at the point of need.

read more

genomic-data-visualised-creative-commons-image-blue-latitude-health

What pharma needs to know about genomic data in 2016

David Cooney | 3rd February 2016

About ten years ago, personalised medicine was a major step forward – tailoring treatments based on individual patient history and information. Fast forward to 2015, and investigating the central dogma of biology is still a major focus of healthcare research. 

Consultant David Cooney talks us through what this progress in genomics means for pharma in 2016.

read more

WIRED-Health-2015-Blue-Latitude-Health

WIRED Health 2015: Key themes and takeaways

Blue Latitude Health | 14th May 2015

James and David from the Blue Latitude Health Strategy team attended WIRED Health 2015, and reported back on what they thought the most exciting and relevant takeaways were for pharma and marketing.

read more

microscope-dna-Blue-Latitude-Health-biomarkers-in-marketing

Use of biomarkers in marketing

Mark Assenti | 12th March 2015

The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by. 

Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.

read more

lightbulb-dna-photo

Is the future of pharma marketing in our DNA?

Mark Assenti | 17th February 2014

Customer data is collected and used by almost every marketing department globally to better target audiences, so is it now time to take the next step, and add DNA to the pharma marketing mix? Mark Assenti explores the ethical and scientific issues behind genetic marketing.

read more